The stock of Cargo Therapeutics CRGX, -3.13%, a clinical-stage biotech specializing in cancer treatments, rose 2.2% in its trading debut on Friday. The deal
Quarterly results from the United States’ largest cannabis company, Curaleaf Holdings Inc., and from Canada’s Canopy Growth Corp. missed analyst estimates, while shares of